KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Invested Capital (2016 - 2026)

Pfizer has reported Return on Invested Capital over the past 18 years, most recently at 0.0% for Q1 2026.

  • Quarterly Return on Invested Capital changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 1.0% up from the prior year.
  • Return on Invested Capital was 0.0% for Q1 2026 at Pfizer, up from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q4 2022 and troughed at 0.01% in Q4 2023.
  • The 5-year median for Return on Invested Capital is 0.0% (2024), against an average of 0.0%.
  • Year-over-year, Return on Invested Capital changed 0bps in 2022 and then decreased -1bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then tumbled by -304bps to 0.01% in 2023, then soared by 78bps to 0.0% in 2024, then fell by -4bps to 0.0% in 2025, then rose by 6bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for PFE's Return on Invested Capital are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).